These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36997061)
61. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers. Masumoto K; Kitagawa M Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119 [TBL] [Abstract][Full Text] [Related]
62. The exploitation of host autophagy and ubiquitin machinery by Shariq M; Quadir N; Alam A; Zarin S; Sheikh JA; Sharma N; Samal J; Ahmad U; Kumari I; Hasnain SE; Ehtesham NZ Autophagy; 2023 Jan; 19(1):3-23. PubMed ID: 35000542 [TBL] [Abstract][Full Text] [Related]
64. Two distinct E3 ligases, SCF Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008 [TBL] [Abstract][Full Text] [Related]
65. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Li S; Lu K; Wang J; An L; Yang G; Chen H; Cui Y; Yin X; Xie P; Xing G; He F; Zhang L Mol Cell Biochem; 2010 May; 338(1-2):11-7. PubMed ID: 19937093 [TBL] [Abstract][Full Text] [Related]
66. The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions. Wang T; Wang W; Wang Q; Xie R; Landay A; Chen D Ann N Y Acad Sci; 2020 Jan; 1460(1):3-10. PubMed ID: 31414713 [TBL] [Abstract][Full Text] [Related]
67. Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity. Humphries F; Moynagh PN Immunol Rev; 2015 Jul; 266(1):93-108. PubMed ID: 26085209 [TBL] [Abstract][Full Text] [Related]
68. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys. Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720 [TBL] [Abstract][Full Text] [Related]
69. E3 Ubiquitin Ligases in Neurological Diseases: Focus on Gigaxonin and Autophagy. Lescouzères L; Bomont P Front Physiol; 2020; 11():1022. PubMed ID: 33192535 [TBL] [Abstract][Full Text] [Related]
70. Regulatory role of E3 ubiquitin ligases in normal B lymphopoiesis and B-cell malignancies. Xu Y; Zheng C; Ashaq MS; Zhou Q; Li Y; Lu C; Zhao B Life Sci; 2023 Oct; 331():122043. PubMed ID: 37633415 [TBL] [Abstract][Full Text] [Related]
71. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer. Uchida C; Kitagawa M Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116 [TBL] [Abstract][Full Text] [Related]
72. Regulation of E3 ubiquitin ligases by homotypic and heterotypic assembly. Balaji V; Hoppe T F1000Res; 2020; 9():. PubMed ID: 32076548 [TBL] [Abstract][Full Text] [Related]
79. Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease. Zhu L; Li Y; Zhou L; Yang G; Wang Y; Han J; Li L; Zhang S Mediators Inflamm; 2020; 2020():5310180. PubMed ID: 32848509 [TBL] [Abstract][Full Text] [Related]
80. E3 ubiquitin ligases and cerebral cortex development in health and disease. Lambert N; Moïse M; Nguyen L Dev Neurobiol; 2022 Jul; 82(5):392-407. PubMed ID: 35476229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]